Plain-English translation of NCT06834685 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing photobiomodulation (PBM)—a treatment using special laser light—to see if it can help reduce nerve pain that develops after chemotherapy. About half of participants will receive real laser light treatment, and the other half will receive a sham (fake) treatment that looks identical. The goal is to find out whether this treatment is safe and actually works for the specific type of nerve pain caused by chemotherapy.
Chemotherapy-induced peripheral neuropathy is a common side effect of cancer treatment that causes chronic pain, numbness, and tingling in the hands and feet. Currently, there are very few proven treatment options for this type of pain, and many standard pain medications don't work well. This trial is exploring whether laser light therapy might be a safe, non-drug option to help.
You likely qualify if…
You likely don't qualify if…
You will visit the cancer institute twice a week for 4 weeks (8 sessions total). During each visit, you'll sit or recline while a clinician applies laser light to your hands and feet for about 13 minutes using a special device. You'll wear protective glasses during the treatment. Half of participants will receive real laser treatment, and half will receive sham treatment that looks exactly the same—you won't know which one you're receiving. Throughout the study, you'll answer questions about your pain levels and other symptoms.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
France